# A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

> **NCT05726682** · PHASE2 · WITHDRAWN · sponsor: **Sanofi**

## Conditions studied

- Allogenic Stem Cell Transplantation

## Interventions

- **DRUG:** SAR445419

## Key facts

- **NCT ID:** NCT05726682
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-08
- **Primary completion:** 2027-02-12
- **Final completion:** 2027-10-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision to cancel trial, not related to safety concern.
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05726682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05726682, "A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05726682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*